About
Cell & Gene Therapy
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyStem Cell & Cellular TherapyVirginia, DC, DE & Maryland
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
5
As Collaborator
2
Total Enrollment
300
By Phase
PHASE2: 1PHASE3: 1PHASE1: 4PHASE1/PHASE2: 1
By Status
ACTIVE_NOT_RECRUITING: 4RECRUITING: 1SUSPENDED: 1COMPLETED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06157151Lead Sponsor
PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
PHASE2Recruiting
46 participants
Started: Mar 21, 2025 · Completed: Jan 30, 2028
NCT06538480Lead Sponsor
Confirmatory Study of PRGN-2012 in Patients With RRP
PHASE3Suspended
42 participants
Started: Jul 11, 2024 · Completed: Mar 1, 2029
NCT05694364Collaborator
Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
PHASE1Active, not recruiting
3 participants
Started: Jan 25, 2023 · Completed: Mar 31, 2026
NCT04724980Lead Sponsor
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
PHASE1/PHASE2Active, not recruiting
38 participants
Started: Mar 16, 2021 · Completed: Jun 5, 2026
NCT03927261Lead Sponsor
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS
PHASE1Active, not recruiting
88 participants
Started: May 20, 2019 · Completed: Aug 1, 2025
Locations (1)
Headquarters
Germantown, MD, United States
Map
Loading map...